Advertisement
Canada markets open in 51 minutes
  • S&P/TSX

    21,740.20
    -159.79 (-0.73%)
     
  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     
  • DOW

    37,735.11
    -248.13 (-0.65%)
     
  • CAD/USD

    0.7242
    -0.0012 (-0.16%)
     
  • CRUDE OIL

    84.97
    -0.44 (-0.52%)
     
  • Bitcoin CAD

    87,442.57
    -3,986.79 (-4.36%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,388.50
    +5.50 (+0.23%)
     
  • RUSSELL 2000

    1,975.71
    -27.47 (-1.37%)
     
  • 10-Yr Bond

    4.6510
    +0.0230 (+0.50%)
     
  • NASDAQ futures

    17,871.25
    -5.00 (-0.03%)
     
  • VOLATILITY

    18.96
    -0.27 (-1.40%)
     
  • FTSE

    7,860.60
    -104.93 (-1.32%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • CAD/EUR

    0.6795
    -0.0029 (-0.43%)
     

Mega-Growers Tapping into the True Global Market Potential of Cannabis

Although all eyes in the cannabis sector are on Canada, the reality is that the remaining global market has far higher potential that Canada’s legalization ever will. However, Canadian cannabis companies are preparing their move for global conquest. The size of the global legal marijuana market is expected to rise to $63.5 billion by 2024, according to a study put out by Ameri Research. Which is why multiple cannabis companies are aggressively targeting markets outside of North America to grow and/or sell their products, including Aphria Inc. (TSX: APHA) (OTC: APHQF), Aurora Cannabis Inc. (TSX: ACB) (OTC: ACBFF), Canopy Growth Inc. (TSX: WEED) (OTC: TWMJF), MedReleaf Corp. (TSX: LEAF) (OTC: MEDFF), and MYM Nutraceuticals Inc. (CSE: MYM) (OTC: MYMMF). The sector is focusing itself internationally into diverse countries such as Australia and New Zealand, Latin America, Europe, and most recently Jamaica and even Malta. Canada’s market alone is projected to reach $22.6 billion after prohibition is lifted. Thanks to the headstart that the country’s legalization-ready ... Click here to view full article